The Journal of clinical endocrinology and metabolism

J Clin Endocrinol Metab · ISSN (e) 1945-7197 · 199 papers in corpus
other 2026
doi:10.1210/clinem/dgaf708 ·PMID:41492807

CONTEXT: Low vitamin D levels have been associated with female infertility, but the underlying mechanisms are not understood. OBJECTIVES: To examine vitamin D treatment, in vitro and in vivo, on human endometrial stromal cell (eSC) decidua…

review 2024
doi:10.1210/clinem/dgae508 ·PMID:39083665

Large-scale studies show endometriosis linked to earlier menopause onset. Recent research targeting women with laparoscopically diagnosed endometriosis found an increase in cases of early natural menopause. Furthermore, recent large-scale c…

meta-analysis 2023
doi:10.1210/clinem/dgad376 ·PMID:37350485

CONTEXT: Extensive studies have provided considerable evidence suggesting the role of inflammation in the development of female reproductive diseases. However, causality has not been established. OBJECTIVE: To explore whether genetically d…

article 2022
doi:10.1210/clinem/dgac118 ·PMID:35235655

CONTEXT: Progesterone resistance including progesterone receptor (PR) deficiency contributes to the pathophysiology of endometriosis; however, whether the PR expression levels in ovarian endometrioma (OE) correlate with the postoperative re…

article 2021
doi:10.1210/clinem/dgab045 ·PMID:33507273

CONTEXT: Small extracellular vesicles (sEVs) have emerged as modulators of the disease microenvironment, thereby supporting disease progression. However, the potential role of EVs and their content to the pathophysiology of endometriosis re…

article 2021
doi:10.1210/clinem/dgab108 ·PMID:33624806

CONTEXT: The ideal therapy for endometriosis (EM) and uterine fibroids (UFs) would suppress estrogenic drive to the endometrium and myometrium, while minimizing vasomotor symptoms and bone loss associated with current treatments. An integra…

article 2021
doi:10.1210/clinem/dgab753 ·PMID:34665857

CONTEXT: Progesterone resistance, a known pathologic condition associated with a reduced cellular response to progesterone and heightened estrogen responses, appears to have a normal physiologic role in mammalian reproduction. The molecular…

article 2020
doi:10.1210/clinem/dgaa618 ·PMID:32877504

PURPOSE: To identify the upstream regulators (URs) involved in the onset and pathogenesis of ovarian endometrioma. METHODS: Recently, a method called Significance-based Modules Integrating the Transcriptome and Epigenome (SMITE) that uses t…

article 2020
doi:10.1210/clinem/dgaa866 ·PMID:33247592

CONTEXT: Enhanced levels of catecholestradiols, 2-hydroxyestradiol (2-OHE2) or 4-hydroxyestradiol (4-OHE2), are reported in endometriosis. During gestation, catecholestradiol activation of adrenergic receptors (AR) elevates estrogen recepto…

article 2020
doi:10.1210/clinem/dgaa189 ·PMID:32282052

CONTEXT: Whether endometriosis is a progressive disease is a highly contentious issue. While progression is reported to be unlikely in asymptomatic deep endometriosis, progression in symptomatic deep endometriosis has recently been reported…

article 2020
doi:10.1210/clinem/dgaa939 ·PMID:33347565

OBJECTIVE: To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TU2670, a novel orally active, nonpeptide gonadotropin-releasing hormone (GnRH) antagonist administered to healthy female participants. METHODS: This…

other 2020
doi:10.1210/clinem/dgaa096 ·PMID:32119078

CONTEXT: NOTCH signaling is activated in endometriotic lesions, but the exact mechanisms remains unclear. IL-6, which is increased in the peritoneal fluid of women with endometriosis, induces NOTCH1 through E-proteins including E2A and HEB …

letter 2020
doi:10.1210/clinem/dgaa541 ·PMID:32798225
article 2020
doi:10.1210/clinem/dgaa550 ·PMID:32813013

CONTEXT: While fibrosis in endometriosis has recently loomed prominently, the sources of myofibroblasts, the principal effector cell in fibrotic diseases, remain largely obscure. Mesothelial cells (MCs) can be converted into myofibroblasts …

letter 2020
doi:10.1210/clinem/dgaa542 ·PMID:32797233
article 2020
doi:10.1210/clinem/dgaa804 ·PMID:33146694

BACKGROUND: Endometriosis (EM) is a benign gynecological disease that shares some characteristics with malignancy, such as proliferation and invasion. So far, the pathogenesis of EM is still unclear. In this study, we investigated whether T…

article 2019
doi:10.1210/jc.2019-00350 ·PMID:31042291

CONTEXT: Regulatory T (Treg) cells and T-helper-17 (Th17) cells may be involved in endometriosis. Information on the pattern of change in the percentages of Treg and Th17 cells in the peripheral blood (PB) and peritoneal fluid (PF) of women…

article 2019
doi:10.1210/clinem/dgz086 ·PMID:31650182

CONTEXT: Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist recently approved for the treatment of endometriosis-associated pain and being developed for heavy menstrual bleeding associated with uterine fibroids. OBJECTIVE:…

article 2019
doi:10.1210/jc.2019-00281 ·PMID:31219551

CONTEXT: The ovarian reserve is reduced in patients with endometriosis. We hypothesize that the phosphatidylinositol 3-kinase (PI3K)-phosphatase and tensin homolog deleted on chromosome 10 (PTEN) Akt-Forkhead box O (Foxo3) pathway is involv…

review 2019
doi:10.1210/jc.2018-01869 ·PMID:30561694

CONTEXT: Infertility affects 10% of the reproductive-age population. Even the most successful treatments such as assisted reproductive technologies still result in failed implantation. In addition, adverse pregnancy outcomes associated with…

letter 2019
doi:10.1210/jc.2018-02494 ·PMID:30657928
article 2019
doi:10.1210/jc.2018-01464 ·PMID:30608536

CONTEXT: Despite extensive searches for novel noninvasive diagnostics, laparoscopy remains the reference test for endometriosis. Circulating miRNAs are purported endometriosis biomarkers; however, the miRNA species and their diagnostic accu…

letter 2019
doi:10.1210/jc.2018-02712 ·PMID:30657936

sponsorship: The original work was supported by National Institutes of Health Grant HD076422 (to H.S.T.). (National Institutes of Health|HD076422)

other 2018
doi:10.1210/jc.2018-01227 ·PMID:30357380

CONTEXT: Progestin-based therapy is the first-line treatment for managing endometriosis-associated pain. However, response to progestins is currently variable and unpredictable. Predictive markers for response to progestin-based therapy wou…

article 2017
doi:10.1210/jc.2017-00052 ·PMID:28575420

Context: Endometriosis is a chronic inflammatory disease associated with altered immune response to endometrial cells facilitating the implantation and proliferation of ectopic endometrial tissues. Although regulatory T (Treg) cells play a …